Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviews
BackgroundNew ways of reimbursement for high-cost, one-shot curative therapies such as advanced therapy medicinal products (ATMPs) are a growing area of interest to stakeholders in market access such as industry representatives, legislative and accounting experts, physicians, hospital managers, hosp...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2025-01-01
|
| Serija: | Frontiers in Pharmacology |
| Teme: | |
| Online pristup: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1397531/full |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
